Abstract: The ability to remotely trigger CRISPR/Cas9 activity would enable new strategies to study cellular events with greater precision and complexity.I nt his work, we have developed am ethod to photocage the activity of the guide RNAc alled "CRISPR-plus" (CRISPR-precise light-mediated unveiling of sgRNAs). The photoactivation capability of our CRISPR-plus method is compatible with the simultaneous targeting of multiple DNAs equences and supports numerous modifications that can enable guide RNAl abeling for use in imaging and mechanistic investigations.
The RNA-guided CRISPR/Cas9 system is agenome-editing technology with broad biological and therapeutic applications. [1, 2] Thef ieldse nthusiasm for the potential of this approach has led to ar apidly expanding toolbox, [3, 4] which includes an approach for site-specific single-gene editing using photoactivatable CRISPR with am odified Cas9 enzyme that incorporates light-responsive domains or sitespecific caging groups. [5] [6] [7] [8] Themajority of the light-activated approaches depend on modifications of the Cas9 enzyme,w hereas recent efforts have modified the single chimeric guide RNA(sgRNA) as an alternative approach to genome editing. [9, 10] In line with this shift, our method, which is called "CRISPR-plus" (CRISPRprecise light-mediated unveiling of sgRNAs), incorporates photocleavable oligonucleotides that complement target regions of the sgRNAi nt he absence of Cas9 modifications. Whereas photocleavable nucleotides have been used in other biological systems, [11] [12] [13] [14] [15] we believe that our report constitutes the first use of photactivatable oligonucleotides in CRISPR activation. While other approaches genetically modify Cas9, [5] [6] [7] [8] our approach does not require any engineering of target cells.A lso,t hese commercially available oligonucleotides are simple to design, chemically synthesize, modify,functionalize,purify,and characterize.Therefore,the photoactivation capability of CRISPR-plus affords simple and convenient control over editing within ag enetic sequence,e nables indirect and transient labeling of sgRNAs,a nd can multiplex different sgRNAs.W ep redict that these features will permit greater mechanistic and causal testing of gene functions and roles in awide range of cellular systems.
To establish CRISPR-plus,w ed esigned complementary ssDNAo ligonucleotides (commercially available from Gene Link, Inc.) or "protectors", of varying lengths and positions along the target region of the guide RNA, and containing photocleavable groups.Whenthe protectors hybridize to the target region of an sgRNA, the resulting complex has ah igh melting temperature (T m ). Thep resence of the hybridized protector thus prevents the sgRNAfrom binding to the target DNAuntil the protector is photolyzed, releasing it from the sgRNA( Figure 1a ;s ee also Supporting Information, Figure S2 and Table S1 c, d). Upon photolysis,t he short fragments of the cleaved protector oligonucleotides will have ar educed binding affinity for sgRNAs owing to their lower T m ,r endering the target DNAs usceptible to Cas9-mediated cleavage.W et ested ar ange of protectors designed to be complementary to the target regions (T) of sgRNAt hat contain photocleavable (PC) groups (PCT1-PCT5) spaced six nucleotides (6-nt) apart, as well as corresponding non-photocleavable control protectors (T1-T5) that do not contain PC groups,u sing an in vitro DNAc leavage assay to determine the efficiency with which they block sgRNAs that target aG FP DNAs equence (Figure 1b and Table S1 c, d). In the absence of light, both the PC-containing p-sgRNA(protected guide RNA) and the non-PC control protectors,p laced near the 5'-end (T3-T5), eliminated virtually all Cas9-mediated cleavage of GFP target DNA, even at the lowest concentration tested (Figure 1b-d and Figure S3 ).
However,after only 2-5 soflight exposure (equivalent to 0.4-1.0 Jcm À2 ,u sing an OmniCure S2000, 365 nm filter, 200 mW cm target DNAw as observed when using several of the PCcontaining protectors,w hereas the non-PC protectors retained their complete blocking efficiencye ven under light irradiation ( Figure S4 ). As an important control, we also confirmed both the purity and photolability of the protectors alone (without sgRNA) using denaturing PAGE gels and/or HPLC ( Figure S5 ). Based on the positioning and length of the most efficient CRISPR-plus protectors for the GFP target sequence (Figure 1b-d and Figure S3 ), we designed and tested protectors for additional GFP target regions as well as two endogenous genes,C D71 and CD33 (Figure 2a nd Figure S6 ). Consistent with our initial findings,a ll six PC protectors afforded protection from DNAc leavage,w hich was lost after exposure to light. These results suggest applicability to other genomic targets.
TheCRISPR-plus method intentionally targets sgRNAto provide distinct advantages over other light-inducible Cas9 methods,y et in doing so,i ti s important to confirm that CRISPR-plus retains the capacity to target multiple guide RNAs simultaneously. [5] [6] [7] [8] To assay for potential multiplex capacity,w e performed aseries of in vitro cleavage assays in which we combined one,two,orall three PC protectors in the presence of GFP,C D33, and CD71 target DNAa nd their corresponding sgRNAs (Figure 3 ; see also Figures S7 and S8). We observed that the light-activated target DNAc leavage response was specific to the presence or absence of the photoactivatable protector sgRNAc omplexes,e ven in the context of mixed targets and mixed sgRNAs equences ( Figure 3 ; see also Figures S7 and S8). Notably,w eo nly observed target DNAc leavage after its cognate sgRNAh ad been unveiled with light-mediated disruption of the protectors.These results suggest that by virtue of its photoactivation capacity,C RIPSR-plus can enable simultaneous,s ynchronized gene editing of multiple targets.
Having established that photolabile protection is mediated by PCcontaining protectors as anticipated in the in vitro cleavage assay,w e sought to determine whether this capacity is maintained in am ore complex cellular environment. To this end, we generated aC as9/ destabilized GFP (Cas9/d2eGFP) co-expressing reporter line using HeLa cells and tested the efficiency of previously screened ssDNAprotectors designed to be complementary to GFP-targeting guide RNA(sgGFP1). To quantify CRISPR activity,weperformed FACS analysis of Cas9/d2eGFP HeLa cells to measure GFP protein expression and, as anticipated, observed an increase in the frequencyo fG FP-negative cells upon addition of sgGFP RNA. We observed areduced efficiency of CRISPRblocking activity in cells with shorter protectors (12-nt and 18-nt) relative to their inhibition of Cas9-mediated DNA cleavage in the in vitro cleavage assay,w hich is possibly due to easier dissociation of shorter protectors inside cells (data not shown). However,when longer ssDNAprotectors (24-nt) containing PC groups were used in the cell-based assay,t he CRISPR-plus system yielded ap opulation change that was conditionally blocked in the presence of PCT5 p-sgGFP prior to exposure to UV light (Figure 4a ,b and Figure S9 ). To further support that the light-mediated loss of p-sgRNAdependent protection of target DNAs equences is mediated À2 )w ith complementary sgGFP1 protectors of different lengths and positions that contain photocleavable (PC) groups spaced 6-nt apart (PCT1-PCT5) or protectors without PC groups (T1-T5), tested using an in vitro cleavage assay (n = 2). c) Representative gel electrophoresis data from the in vitro cleavage assay for a2:1 ratio of protector PCT5/sgRNA.T he 702 bp target GFP DNA was cut to yield 563 bp and 139 bp fragments in the presence of sgRNA, but only after p-sgRNA photolysis (l = 365 nm, 6.0 Jcm À2 ). All presented samples were run on asingle physical gel, and cropped images of marked lanes are shown to streamline figure presentation. Lanes in which 1x concentrations of protectors were added are shown in Figure S3 . d) Quantification of replicate in vitro assays from (c), where data is expressed as af raction of uncleaved DNA, as calculated based on band intensities. Data were normalized to control untreatedD NA, and mean values with standard deviation are plotted (n = 3). An unpaired Student's t-test was performed for sgRNA with PCT5 in the presence or absence of light exposure, and p values are represented by asterisks, ***p < 0.001.
by genomic DNAc leavage,w ep erformed aS URVEYOR nuclease assay on intact Cas9/d2eGFP HeLa cells and measured the percentage of indels (insertion/deletion mutations) according to published methods. [16] We observed lightinsensitive indel formation with the transfection of GFP-or CD71-targeted sgRNA, whereas the inclusion of the appropriate PC protector RNAf or either target reduced indel formation. Furthermore,this protection from Cas9-mediated cleavage was diminished after exposure to UV light (4.0 Jcm À2 at 365 nm, generated using aC L-1000 UV crosslinker UVP light source with ap ower density of 4.45 mW cm À2 ,a sm easured by an OAI306 UV power meter) for both GFP and CD71 (Figure 4c,d ). It has previously been confirmed in multiple studies that as ingle exposure to 365 nm UV irradiation of up to 5.0 Jcm À2 is nonphotogenotoxic in the HaCaT (human keratinocyte) cell line, [17] and such radiation has also been used in different tumor models in vivo, [14, 18, 19] which is consistent with the lack of overt acute photocytotoxicity observed in our approach ( Figure S10 ).
We developed CRISPR-plus as am odular approach that employs ap hotocleavable complementary oligonucleotide against the target region of sgRNAs to achieve inducible, target-specific editing of any gene(s) of interest. This lightdependent approach allows for the simultaneous targeting of multiple sequences and offers the possibility of achieving temporal precision in the activation of sgRNAs.U sing the CRISPR-plus method, we achieved the targeted cleavage of the PCR products of three genomic sequences,including two genes relevant to multiple myeloma and acute myeloid leukemia development. [20] [21] [22] This removable protector approach can be immediately extended to numerous Cas nuclease and sgRNAv ariants with other effector functions. [9, [23] [24] [25] [26] [27] [28] [29] Recently,D eiters and co-workers reported ac aged Cas9 approach that achieved ar obust off/on switch for multiple sgRNAs in cells,m inimal leakage of Cas9 activity in the absence of light, and robust recovery of Cas9 activity in asubset of sgRNAs after light exposure. [7] In comparison, our system also showed ar obust off/on switch in an in vitro cleavage assay,using multiple guide RNAs individually and in combination, but our dynamic range was lower when tested in cells.W ed id observe some light-independent cleavage activity after day 5( data not shown), which is possibly due to complex dissociation inside cells.D espite this timedependent leakage of activity,a ni mportant distinguishing factor is that our approach is based on sgRNAmodifications, and thus it opens up new possibilities for modifying,controlling,and improving CRISPR activity by non-genetic methods.
In an attempt to improve the dynamic range and to test whether protectors can tolerate modifications that may enable future functionalization, we 1) changed the backbone of the protectors to RNAo r2 '-OMe RNA, 2) decreased the number of PC groups on the ssDNAp rotector,a nd 3) modified the 3'-end of ssDNAprotectors to sterically block the 5'-end of sgRNA. Each of these modifications was tested in cells, with or without pre-irradiation ( Figure S11 ). In the first case, despite achieving am ore stable RNA/sgRNAd uplex, the RNAp rotectors showed very poor blocking of CRISPR activity ( Figure S11 ), whereas 2'-OMe RNAp rotectors performed similarly to DNAp rotectors.S econd, decreasing the number of PC groups in a2 4-nt protector resulted in ac omparable blocking of activity in the absence of light, but activation of the CRISPR activity in the presence of light was not as robust (slightly reduced), which is likely due to the higher residual binding of the 8-nt protector fragments compared to 6-nt spaced PC groups.F inally,t he addition of aF AM dye to the 3'-end of assDNAprotector yielded strong ). The percentage of uncleaved DNA was calculated from the band intensities of the gels ( Figure S6 ). Data were normalized to the cleavage of control untreatedD NA. Mean values with standard deviation are plotted for multiple repeat experiments (sgGFP-2, sgGFP-3, and sgCD71-1: n = 4; sgCD71-2 and sgCD33-1: n = 2; sgCD33-3: n = 2, with T11: n = 1). An unpaired Student's t-test was performed between irradiated and non-irradiated samples, as described in the data analysis section in the Supporting Information,and p values are represented by asterisks, *p < 0.05, **p < 0.01, ****p < 0.0001.
inhibition of CRISPR activity in the absence of light and resulted in robust CRIPSR-plus activity,s imilar to that observed using an unmodified ssDNAprotector. This finding emphasizes that protectors tolerate modifications near the 5'-end of sgRNA, and highlights that they are thus amenable for use in indirect labeling of sgRNAs while maintaining their utility as aC RISPR-plus switch.
While we acknowledge that our first-generation CRISPRplus method lacks ap erfect off/on switch, we believe that it still offers an attractive,simple approach to many researchers that they can adapt for their own applications by further modifying the protectors or by conjugating the protector to the sgRNA. Notably,D oudna and co-workers have shown that 10-nt ssDNAcan stabilize the Cas9/sgRNAcomplex and hence is required for target binding with Cas9/sgRNA. [30] Our efforts extend these findings to highlight that the position of ssDNAb inding to the sgRNAi mpacts Cas9-mediated cleavage (Figure 1b) and may also influence enzyme binding to the complex.
Further studies may provide additional mechanistic insight as well as improved control and specificity.W hereas our current version of genome editing by CRISPR-plus activation of sgRNAs is irreversible and depends on activation with UV light, the activation duration should be controllable by modulating the Cas9/sgRNAp ersistence,a nd orthogonal photocleavable groups can be employed to achieve multiplexed activation of protectors in as patiotemporally controlled manner.F uture generations of CRISPRplus could also incorporate photocleavable oligonucleotides across the sgRNAb ackbone region to yield universal, offtarget, sequence-agnostic protectors or other modified sgRNAs designed to mediate selective blockade and thereby prevent the recruitment of other effector domains. [9] Overall, our CRISPR-plus method provides ar apid and simple approach for the light-mediated control of genome editing. For photolysis rate experiments, p-sgRNAs were also irradiated for 1s, 2s, 5s, 10s or 15s using the same setup.
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Amplification of DNA target amplicons
GFP, CD71 and CD33 genes were amplified from cells using Terra TM PCR Direct Polymerase followed by High Yield EcoDry PCR (Clontech) by following manufacturer's protocol and primer sequences described in Supporting Table 1e .
In vitro cleavage assay and multiplexing
In vitro cleavage assay was performed by using recombinant Cas9 from NEB and PNA Bio. Briefly, 100 ng of DNA amplicon, 60 ng of sgRNA, 1 g of BSA and 500 ng of Cas9 were incubated with 10 L of 1x of Cas9 buffer (NEB) in RNase free water for 1 hr at 37 o C. Reaction COMMUNICATION was quenched by adding SDS containing loading dye (NEB) and loaded onto a 1.5% agarose gel containing 1.5x GelRed dye (Biotium, Inc) for visualization.
Generation of Cas9/d2eGFP cell line
To test CRISPR activity in cells we generated HeLa cells with constitutive Cas9
expression. HeLa-d2eGFP cells were transduced with CAG-h Cas9 (Puro) lentiviral particles (Gentarget Inc.) by spin infection in the presence of 3 µg/ml polybrene. Two days after transduction, 2 µg/ml puromycin was added to the media for one week to select for Cas9 expressing cells. Subsequently, the cells were sorted for GFP+ cells using flow cytometry.
(HeLa-d2eGFP, HeLa cells expressing destabilized GFP, were a gift from Prof. Phillip A. Sharp,
MIT)
Transfection of cells and mutation detection
To replaced with the fresh medium. Cells were cultured for another 48 to 72 hours and then GFP levels were analyzed using flow cytometry. Mutations were detected in the genomic DNA using
Guide-it Mutation Detection Kit (Clontech) by following manufacturer's protocol and using primer sets described in Table 1f .
COMMUNICATION
Cytotoxicity studies
Cas9/d2eGFP expressing HeLa Cells were plated in a 96-well plate at a density of 8,000
cells/well in 10% FBS/DMEM containing 1% penicillin streptomycin antibiotic media. Similar to all the other cell based experiments, 24 hours later cells were either kept in dark or exposed to 4.0 J/cm 2 (15 min) of light with at a wavelength of 365 nm, using a CL-1000 UV Cross-linker UVP with power density of 4.45 mW/cm 2 as measured by an OAI 306 UV power meter. 72 hours post irradiation, media was replaced with fresh media and cell toxicity was determined using PrestoBlue® Cell Viability Reagent (ThermoFisher) by following manufacturer's protocol.
Briefly, wells with cells or without cells (background) were incubated for 45 min in the media containing the reagent and then fluorescence was measured using a fluorescence spectrophotometer (Tecan). Please refer Figure S10 for more details.
Irradiation of protectors and their characterization by gel and HPLC analysis
Different protectors in RNase free water (50 M, 10 L, see figure S5 ) were either kept in dark or exposed to 30 seconds (or 6 J/cm 2 ) of light exposure using a UV laser source (OmniCure S2000, 365 nm filter, 200 mW/cm 2 ). 2 L of this sample was then mixed 1L of SDS-containing gel loading dye (NEB B7021S) and were loaded on a denaturing PAGE gel containing 10% TBE urea (Invitrogen) for gel electrophoresis. Following electrophoresis, gel was stained with 2x
GelRed staining dye (Biotium) and then analyzed on a gel doc imager. The remaining sample was diluted 5 times with water and then analyzed by HPLC using a modified protocol from the literature.
[33] Briefly, a 250 × 4.5 mm C8 column was used with mobile phase containing 0.1 M triethylammmonium acetate buffer (A) and a mixture of 50% acetonitrile and 50% 0.1 M triethylammmonium acetate buffer (B). 40 L of sample was injected in the HPLC and samples were ran using a gradient: 100% A to 100% B over 30 min at a flow rate of 1 ml min −1 .
COMMUNICATION
Data analysis
Gels were imaged using a Kodak Gel Logic 200 imaging system and band intensities were analyzed using Fiji (ImageJ) software. Background band intensities were individually calculated for each lane near the band and subtracted from each band individually to correct for non-uniformity in the scanning of the gel. % Uncleaved DNA was calculated by using the formula % Uncleaved DNA= 100 x (a)/(a + b + c), where a is integrated intensity of uncleaved DNA while b and c are integrated intensity of cleavage products after background correction.
The data was then normalized to 100% for the control DNA sample without Cas9. % indels were calculated based on the binomial probability distribution of duplex formation using following . Following exposure, 350 pmols of samples was injected in HPLC using the method described in the methods section, and 100 pmols of protectors was loaded on a denaturing PAGE gel. As expected, T5 protector showed no effect of light while PCT5 showed complete degradation after the irradiation. First nucleotide incorporated into sgRNA is underlined. Note that some sequences have an extra G or GG incorporated into guide RNAs due to use of T7 promoter. 
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